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Abstract
Background: Irritable bowel syndrome (IBS) is largely viewed as a stress-related disorder caused by aberrant brain-gut–
immune communication and altered gastrointestinal (GI) homeostasis. Accumulating evidence demonstrates that stress
modulates innate immune responses; however, very little is known on the immunological effects of stress on the GI tract.
Toll-like receptors (TLRs) are critical pattern recognition molecules of the innate immune system. Activation of TLRs by
bacterial and viral molecules leads to activation of NF-kB and an increase in inflammatory cytokine expression. It was our
hypothesis that innate immune receptor expression may be changed in the gastrointestinal tract of animals with stress-
induced IBS-like symptoms.
Methodology/Principal Findings: In this study, our objective was to evaluate the TLR expression profile in the colonic
mucosa of two rat strains that display colonic visceral hypersensivity; the stress-sensitive Wistar-Kyoto (WKY) rat and the
maternally separated (MS) rat. Quantitative PCR of TLR2-10 mRNA in both the proximal and distal colonic mucosae was
carried out in adulthood. Significant increases are seen in the mRNA levels of TLR3, 4 & 5 in both the distal and proximal
colonic mucosa of MS rats compared with controls. No significant differences were noted for TLR 2, 7, 9 & 10 while TLR 6
could not be detected in any samples in both rat strains. The WKY strain have increased levels of mRNA expression of TLR3,
4, 5, 7, 8, 9 & 10 in both the distal and proximal colonic mucosa compared to the control Sprague-Dawley strain. No
significant differences in expression were found for TLR2 while as before TLR6 could not be detected in all samples in both
strains.
Conclusions: These data suggest that both early life stress (MS) and a genetic predisposition (WKY) to stress affect the
expression of key sentinels of the innate immune system which may have direct relevance for the molecular
pathophysiology of IBS.
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Introduction
Irritable Bowel Syndrome (IBS) is a highly prevalent functional
disorderofthe gastrointestinaltractcharacterizedbythe presenceof
abdominal pain or discomfort, an alteration in bowel habit and the
absence of reproducible biomarkers [1,2]. It can result in significant
impairment in quality of life and in psychological function. The
precise molecular pathophysiology remains to be elucidated but
altered visceral perception (visceral hypersensitivity) and gut
dysmotility are important contributors to symptom progression
[3,4]. IBS is generally viewed as a disorder of the brain-gut axis with
stress playing an important role [5,6]. Moreover, accumulating
evidence demonstrates that IBS patients display an over-activation
of the hypothalamic-pituitary adrenal (HPA) axis which is crucial
for integration of the body’s response to stress [7].
Recently, we and others, have reported immune dysfunction in
IBS patients [7–10]. Systemic inflammation is known to activate
the HPA axis [11] and may account for the exaggerated HPA axis
response reported in IBS such as the elevations in the
inflammatory cytokine interleukin-6 (IL-6) [7]. Furthermore, it
has also been shown that baseline levels of tumour necrosis factor
a (TNFa), interleukin-1b (IL-1b) and IL-6 were elevated in
diarrhoea predominant IBS patients (D-IBS) [10]. It is not known
what causes this elevation in pro-inflammatory cytokines in the
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contrast to post-infectious IBS (PI-IBS), where IBS symptoms
develop following a gastrointestinal infection. This is thought to be
due to residual inflammation post-infection and persistent changes
in the colonic mucosal immune system and microbiota [12].
Toll-like receptors (TLRs) are members of the pattern
recognition receptor family and play a central role in the initiation
of innate cellular responses and the subsequent adaptive immune
response to a variety of pathogens. There are ten TLRs in humans
and they recognise different microbial ligands during infection
[13]. There is also growing evidence to indicate that certain TLRs
also sense products of damaged tissue [14]. Activation of the TLRs
by either pathogenic ligand or host factors results in activation of
downstream transcription factors such as NF-kB and IRF-3
resulting in expression of immune and inflammatory genes. TLRs
are activated by various components of both bacterial and viral
cell components e.g. TLR4 binds lipopolysaccharide (LPS) in
gram-negative bacteria and TLR7 binds single stranded RNA
(ssRNA) from viruses. Following receptor binding, a cellular
protein cascade is initiated which results in the activation of NF-kB
amongst other transcription factors, which in turn transcribe
inflammatory cytokines [15–17]. TLRs are present on a variety of
cell types and are found on colonic mucosal surfaces [18]. Few
studies have investigated the impact of chronic stress on TLR
expression and function, however of those that have done so,
repeated social defeat stress has been shown to increase the
expression of TLR2 and TLR4 [19] and increase TLR-mediated
release of pro-inflammatory cytokines from splenic monocytes and
dendritic cells [20]. Chronic restraint stress has also been shown to
increase the expression of TLR4 in the spleen [21] and promotes
immune suppression via PI3K signalling [22]. In this study, our
objective was to examine the TLR expression profile in the colonic
mucosae of two chronic stress models, the maternal separation
(MS) model and Wistar-Kyoto (WKY) rats. MS rats show
increased visceral hypersensitivity, increases in pro-inflammatory
cytokine secretion following LPS stimulation and differences in the
intestinal microbiota when compared to non separated (NS) rats
[23]. Furthermore, MS rats have increased colonic permeability
and increased mast cell protease release and number in the colonic
mucosa [24,25]. This mast cell activity was subsequently shown to
occur in close apposition to enteric nerves [25], which is similar to
that seen in IBS patients [24]. The WKY rat is a selectively bred
strain that is hyper-responsive to stress [26,27]. In particular,
WKY rats have marked elevations in stress- and depression-
associated changes when compared to Sprague Dawley (SD) rats,
the strain most commonly used as a control comparator [28]. In
addition to the depressed and anxious phenotype, increased
sensitivity to colorectal distension (CRD) has been reported
[23,29,30] coupled with alterations in colonic and gastric
accommodation [31,32] and colonic morphology [33] and
function [34,35] further supporting the use of these animals as a
model relevant to IBS. Given that both MS and WKY rats are
purported to have alterations in their stress and immune responses
in addition to IBS-related behavioural and visceral hypersensitivity
changes, we hypothesised that there could be changes in innate
immune receptor expression in the gastrointestinal tract. We
therefore investigated whether there were any perturbations in
TLR mRNA in the colonic mucosa in both models.
Materials and Methods
Animals
Male SD and WKY rats (200–250 g,) were obtained from
Harlan UK. Animals were allowed to acclimatise to our animal
facility for at least one week. Temperature and light (12 hr light:
12 hr dark) were controlled, while intake of food and water were
provided ad libitum. MS of facility reared SD rats was carried out
from P2-P12 for 3 h per day as previously described [23]. Briefly,
the MS rats were removed from their home cages at P2 and placed
into plastic cages maintained at 30–33uC, in a separate room.
Separations lasted for 3 h/day until P12 from 9:00 am until 12:00
pm. The NS groups were left undisturbed with their mothers.
Experimental group sizes were determined by a power
calculation to detect differences at the 0.05 level. Following
euthanasia by inhalable anaesthetic (isoflurane 2%) followed by
decapitation; colonic mucosal scrapings (n=5 per group) from
distal and proximal colonic mucosa were collected at ,8 weeks of
age. Given that the distal and proximal colon contribute to
different physiological functions the mucosae from each was
analysed separately to assess if there also differed in their
expression of TLRs. Specifically, the proximal colon stores
food/faeces and has a major function in reabsorbing water and
electrolytes whereas the distal colon has a greater role in the
propulsion of the faeces out of the colon, in addition to fluid
absorption [36]. Mucosal scrapings were stored in RNA Later
(Ambion, Warrington, UK) at 280uC for analysis at a later date.
Approval for this study was granted by University College Cork’s
Animal Experimentation Ethics Committee (Ethics Approval
number & date).
Sample Preparation
Colonic mucosal scrapings were homogenized using a Polytron
PT2100 in RNA lysis buffer until all solids were lysed (Stratagene,
La Jolla, USA). RNA extraction was carried out using the
Stratagene Absolutely RNAH Miniprep kit according to manu-
facturer’s instructions. Briefly, nucleic acids were extracted using a
buffer and spin column protocol. The nucleic acids were then
washed and separated using an elution column. DNase treatment
subsequently removed any DNA and was carried out using the
Ambion Turbo DNase kit (Ambion, Warrington, UK) according
to manufacturer’s instructions. RNA was quantified using
NanoDrop
TM spectrophotometer according to the manufacturer’s
instructions. RNA quality was assessed using the Agilent
TM
Bioanalyzer (Agilent, Stockport, UK) according to the manufac-
turer’s procedure and an RNA integrity number (RIN) was
calculated. RNA with RIN value .7 was used for subsequent
experiments. RNA was reverse transcribed to cDNA using the
Applied Biosystems
TM High Capacity cDNA kit (Applied
Biosystems, Warrington, UK) according to manufacturer’s in-
structions. Briefly, Multiscribe Reverse Transcriptase (50 U/mL)
was added as part of RT master mix, incubated for 25uC for
10 mins, 37uC for 2 hrs, 85uC for 5 mins and stored at 4uC.
Quantitative Real-Time PCR
Quantitative PCR (Q-PCR) was carried out using probes (6
carboxy fluorescein - FAM) designed by Applied Biosystems
TM to
rat specific Toll-like receptors (TLR) 2–10 while using b-Actin as
an endogenous control. Q-PCR was carried out on the ABI7300
Real Time PCR machine (Applied Biosystems, Warrington, UK).
Samples were heated to 95uC for 10 mins, and then subjected to
40 cycles of amplification by melting at 95uC and annealing at
60uC for 1 min. Experimental samples were run in triplicate with
2 mL cDNA per reaction. To check for amplicon contamination,
each run contained no template controls in triplicate for each
probe used. Cycle threshold (Ct) values were recorded. Data was
normalised using b-Actin and transformed using the 2
2DCt
method [37].
Stress Increases Gut TLR mRNA
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8226Statistical Analysis
Data are expressed as mean +/2 SEM. Statistical differences
weredetermined using Student’s t-testwitha correction for multiple
comparisons. All tests were performed using GraphPad Prism 4
statistical software. Statistical significance was indicated as follows:
* indicates p,0.05; ** indicates p,0.01 & *** indicates p,0.001.
Results
TLR Expression in Maternally Separated (MS) Compared
with Non-Separated (NS) Tissues
Early life stress causes perturbations in brain gut-immune axis
function [23,38,39]. Chronic stress has also been shown to alter
TLR expression in immune cells [20,19]. This led us to investigate
if this might result in changes in the expression of TLRs in the
colonic mucosa. Comparing mRNA levels, we see a significant
difference in the levels of TLR3, the receptor for dsRNA [40], in
the proximal (p=0.0006) and the distal colonic mucosa (p=0.009)
(Figure 1c & 1d), TLR4 (Figure 1e & 1f), the receptor for LPS, [41]
in the proximal (p=0.0035) and the distal colonic mucosa
(p,0.0001) & TLR5 (Figure 1g & 1h), the receptor for flagellin,
[42] in the proximal (p=0.0007) and the distal colonic mucosa
(p,0.0001). While TLR8 was significantly increased in the
proximal but not the distal colon (p=0.0359) (Figure 2c). No
significant differences were noted for TLR2, 7, 9 & 10 while TLR6
could not be detected in all samples in both rat strains.
TLR Expression in Wistar Kyoto (WKY) Compared with
Sprague-Dawley (SD) Tissues
The WKY rat also displays visceral hypersensitivity [30] and a
highly anxious phenotype [39]. In comparison to normo-anxious
SD rats. WKY animals have increased mRNA expression of
TLR3 in the proximal (p=0.0072) and the distal colonic mucosa
(p=0.00477) (Figure 3 c & 3d), TLR4 in the proximal (p,0.0001)
and the distal colonic mucosa (p,0.0001) (Figure 3e & 3f) and
TLR5 in the proximal (p=0.05) and the distal colonic mucosa
(p,0.0001) (Figure 3g & 3h). Moreover the expression of TLR7 in
the proximal (p=0.0004) and the distal colonic mucosa
(p=0.0203) (Figure 4a & 4b), TLR8 in the proximal (p,0.0001)
and the distal colonic mucosa (p,0.0001) (Figure 4c & 4d), TLR9
in the proximal (p=0.0015) and the distal colonic mucosa
(p=0.007) (Figure 4e & 4f) and TLR10 in the proximal colonic
mucosa only (p=0.0331) (Figure 4g) was greater when compared
to the SD colonic mucosa. No significant differences in expression
were found for TLR2 (Figure 3a & 3b) while as before, TLR6
could not be detected in all samples in both strains. The WKY rat
strain appears to show differences compared to the SD strain in
the same TLRs as the MS versus NS rats but also in several other
TLRs, namely TLR7, 8, 9, 10. The functional significance of this
is not known at present. TLR7 is known to bind to ssRNA from
viruses [43] and TLR9 is known to bind to methylated DNA from
bacteria and viruses [44] while there is no known ligand for
TLR10 at present. Increases in these TLRs may result in increased
inflammatory cytokine production and subsequent release into the
circulation [45].
Discussion
IBS is characterized by recurrent abdominal pain or discomfort
at least 3 days per month for the past three months, associated
with improvement of symptoms with defecation, onset associated
with a change in the frequency and form/appearance of stool [46].
The syndrome has a worldwide prevalence of 10 to 15% [1], and
chronic stress and anxiety have been thought to be major
contributors to some of the symptoms of IBS [47]. There is an
ongoing need to develop more models of irritable bowel syndrome
in mice and rats to investigate the effects of chronic stress on the
physiology of the gut because of the current lack of pharmaco-
logical treatments and complete understanding of the underlying
causes. Two proposed rat models of IBS, the MS and WKY
models used in this study have been shown to display changes in
brain, gut and immune function that are relevant to the
manifestation of IBS symptomatology [23,30,39].
At present there is a lack of reliable biomarkers in IBS patients
[48]. It has been suggested that plasma cytokines maybe a putative
biomarker for IBS. Pro-inflammatory cytokines such as IL-6, the
IL-6 soluble receptor and IL-8 were all found to be elevated in IBS
patients [7]. The increase in IL-6 and IL-8 may be linked to
muscarinic receptor activity [49]. Another study has also found
similar results, where IBS patients were shown to have increased
levels of TNFa, IL-1b, IL6 at baseline and higher levels of LPS-
induced IL-6 released in proximity or into circulation [10].
Previous work has shown that there are increased numbers of
CD3+ and CD25+ in the lamina propria of IBS patients [50]. In
addition, recent studies have also reported B-cell [51] and T-cell
[52] activation in IBS patients suggesting aberrant immune
activation. However, the origin of the cytokine release is not fully
understood. One possible source of pro-inflammatory cytokine
release is via activation of TLRs [45].
In this study, we have focussed on the expression of TLRs in the
colonic mucosa, TLRs are key inducers of inflammation and to
our knowledge, and this study shows for the first time that chronic
stress in two animal models may affect the regulation of TLR
expression in the colonic mucosa. In particular we demonstrate
that both models display changes in the mRNA expression of
TLR3, 4 and 5. As the ligands for these TLRs are both viral and
bacterial this indicates that the stress models used in these
experiments does not cause upregulation of any particular sub
group of TLRs but results in a general increase in the level of these
immune receptors. The upregulation of TLRs 4 and 5 suggests a
potential increase in sensitivity to the presence of bacteria in the
gut resulting in increases in cytokine production. Further studies
will be needed to clarify if this is indeed the case. Interestingly, the
increases seen in the WKY rat are somewhat different to the MS
rats when both are compared to respective controls, indicating that
these qualitatively different stressful states may differentially affect
the expression of members of the innate immune receptors.
Detailed comparisons between these two models may allow us to
investigate further what factors may cause this differential
expression. Possible reasons for these differences may lie in
differences in neuroendocrine responses of the strains or the
resident microbiota. We have shown that the MS model has
different populations of microbiota in the gut compared to NS rats
[23]. Studies analysing the microbiota in the WKY rat are
ongoing. It is not known at present whether it is stress-induced
changes in innate immune receptors facilitates the propagation of
certain populations of bacteria or stress-induced changes in
microbiota that lead to changes in innate immune receptor
expression. Aside from the GI tract previous studies have shown
that chronic stress may affect the expression of certain TLRs on
circulating immune cells [19,20] and our current data extend such
observations to the GI colonic mucosae. It is not certain if other
stress models share a similar pattern of expression as the ones
mentioned in this study. We are unaware of other studies
examining the immune effects of other chronic stress models in
the GI tract but this is currently under investigation by our group.
It is not known at present what mechanism causes the increased
expression of certain TLRs in the colonic mucosae of the MS and
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PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e8226Figure 1. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of non-separated (NS) and
maternally-separated (MS) Sprague-Dawley rats. TLR2 (a, b), TLR3 (c, d), TLR4 (e, f) & TLR5 (g, h) mRNA levels are shown in both the proximal (a,
c, e & g) and the distal (b, d, f & h) colon. Data was normalized to b-Actin and expressed using the 2
2DCt method. (** indicates p,0.01, *** indicates
p,0.001).
doi:10.1371/journal.pone.0008226.g001
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PLoS ONE | www.plosone.org 4 December 2009 | Volume 4 | Issue 12 | e8226Figure 2. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of non-separated (NS) and
maternally-separated (MS) Sprague-Dawley rats. TLR7 (a, b), TLR8 (c, d), TLR9 (e, f) & TLR10 (g, h) mRNA levels are shown in both the proximal
(a, c, e & g) and the distal (b, d, f & h) colon. Data was normalized to b-Actin and expressed using the 2
2DCt method. (** indicates p,0.01, *** indicates
p,0.001).
doi:10.1371/journal.pone.0008226.g002
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PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8226Figure 3. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of Wistar-Kyoto (WKY) and
Sprague-Dawley (SD) rats. TLR2 (a, b), TLR3 (c, d), TLR4 (e, f) & TLR5 (g, h) mRNA levels are shown in both the proximal (a, c, e & g) and the distal
(b, d, f & h) colon. Data was normalized to b-Actin and expressed using the 2
2DCt method. (** indicates p,0.01, *** indicates p,0.001).
doi:10.1371/journal.pone.0008226.g003
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PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8226Figure 4. Relative levels of Toll-like Receptor (TLR) mRNA in the distal and proximal colonic mucosa of Wistar-Kyoto (WKY) and
Sprague-Dawley (SD) rats. TLR7 (a, b), TLR8 (c, d), TLR9 (e, f) & TLR10 (g, h) mRNA levels are shown in both the proximal (a, c, e & g) and the distal
(b, d, f & h) colon. Data was normalized to b-Actin and expressed using the 2
2DCt method. (** indicates p,0.01, *** indicates p,0.001).
doi:10.1371/journal.pone.0008226.g004
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levels of glucocorticoids in addition to catecholamines, growth
hormone and prolactin, all of which, have different effects on the
immune system [53]. Corticosterone is elevated basally in the MS
model [23] and shows a sustained increase following stress in the
WKY model [54]. Glucocorticoids appear to be able to regulate
the expression of certain TLRs. Of note it has been shown that
glucocorticoids may synergize with either IL-1b [55], TNFa [56]
or H. influenzae [57] to enhance the expression of TLR2 in human
colonic or alveolar epithelial cells. A similar mechanism may exist
in the stress models examined here with both showing greater
stress-induced levels of glucocorticoids. Other mediators have
been mentioned to affect TLR expression including catechol-
amines such as noradrenaline [58]. Infection with the obligate
parasite T. gondii has been shown to increase expression of certain
TLRs (TLR2, 4, 9 & 11 (murine)) while cold water stress following
infection seems to decrease the expression of the same TLRs [58].
Noradrenaline treatment increased basal levels of certain TLRs
while decreasing their expression in epithelial cells following T.
gondii infection [58]. This may have relevance to IBS as
catecholaminergic activity is often altered in such patients [59].
Moreover, in addition to bacterial components, fatty acids [60,61]
and opioids [62] have recently been shown to interact with TLR4
at least. These are also possibly other as yet unknown ligands that
may interact with TLRs and result in the increase in cytokines
seen in IBS patients
Another key question arising from this study is whether the
changes in TLR expression are a state or trait marker of IBS-
related symptomatology. Both these animal display visceral
hypersensitivity in response to colorectal distension [23,30]. TLRs
may play an important role in visceral pain by indirectly increasing
pro-inflammatory cytokine expression. It has been shown in
models of neuropathic pain, where there is spinal nerve axotomy,
genetic deletion of TLR2 [63], TLR3 [64] and TLR4 [65] results
in reduced hypersensitivity and allodynia. More recently a TLR4
antagonist showed efficacy in a mouse peripheral nerve injury
model [66]. The primary mechanism suggested in these studies is
that pain results from spinal glial activation. Recently, it has been
demonstrated that spinal microglia may play a key role in visceral
hypersensitivity in a rat chronic stress model [67]. Inflammatory
cytokine production from TLR activation may result in activation
of glial cells on spinal nerves that innervate the gut.
In conclusion we have shown alterations in TLR expression
levels in two models of stress which display symptoms relevant to
IBS. Future studies will hopefully answer what specific chain of
events causes the selective increase in TLR expression, how these
are manifested at the protein level and what the functional
significance of these increases are in terms of symptom
manifestation in IBS. The future availability of high-quality
specific antibodies targeting the various rodent TLRs would also
be a major assistance in such exploits. Moreover, future
investigations comparing the changes observed herein with those
from other in vivo models of GI dysfunction (e.g. colitis) and/or
stress are also warranted. Finally the translation of such findings
into the clinical setting may pave the way for a novel biomarker of
IBS where there is an immense medical need [48].
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